A detailed history of Los Angeles Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 15,355 shares of ABT stock, worth $1.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,355
Previous 70,064 78.08%
Holding current value
$1.77 Million
Previous $7.28 Million 75.96%
% of portfolio
0.01%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$100.07 - $118.13 $5.47 Million - $6.46 Million
-54,709 Reduced 78.08%
15,355 $1.75 Million
Q2 2024

Aug 05, 2024

SELL
$100.73 - $112.44 $3.06 Million - $3.41 Million
-30,364 Reduced 30.23%
70,064 $7.28 Million
Q1 2024

Apr 05, 2024

SELL
$109.52 - $120.96 $20.9 Million - $23.1 Million
-190,619 Reduced 65.49%
100,428 $11.4 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $706,819 - $865,204
7,837 Added 2.77%
291,047 $32 Million
Q3 2023

Nov 06, 2023

SELL
$95.53 - $114.62 $3.51 Million - $4.21 Million
-36,736 Reduced 11.48%
283,210 $27.4 Million
Q2 2023

Aug 03, 2023

BUY
$100.78 - $112.29 $24.4 Million - $27.1 Million
241,737 Added 309.09%
319,946 $34.9 Million
Q1 2023

May 04, 2023

BUY
$96.86 - $114.01 $1.5 Million - $1.77 Million
15,534 Added 24.79%
78,209 $7.92 Million
Q4 2022

Feb 06, 2023

SELL
$95.06 - $111.52 $8.32 Million - $9.77 Million
-87,575 Reduced 58.29%
62,675 $6.88 Million
Q3 2022

Nov 02, 2022

SELL
$96.76 - $112.03 $4.65 Million - $5.38 Million
-48,050 Reduced 24.23%
150,250 $14.5 Million
Q2 2022

Aug 05, 2022

SELL
$102.07 - $123.37 $12.5 Million - $15.1 Million
-122,353 Reduced 38.16%
198,300 $21.5 Million
Q1 2022

May 06, 2022

SELL
$114.02 - $139.04 $8.61 Million - $10.5 Million
-75,526 Reduced 19.06%
320,653 $38 Million
Q4 2021

Feb 03, 2022

SELL
$115.53 - $141.46 $13.8 Million - $16.9 Million
-119,642 Reduced 23.19%
396,179 $55.8 Million
Q3 2021

Nov 08, 2021

SELL
$116.66 - $129.06 $19.6 Million - $21.6 Million
-167,613 Reduced 24.53%
515,821 $60.9 Million
Q2 2021

Aug 05, 2021

SELL
$105.79 - $124.53 $33 Million - $38.8 Million
-311,587 Reduced 31.31%
683,434 $79.2 Million
Q1 2021

May 05, 2021

SELL
$108.84 - $128.23 $9.92 Million - $11.7 Million
-91,110 Reduced 8.39%
995,021 $119 Million
Q4 2020

Feb 04, 2021

BUY
$105.0 - $114.42 $3.07 Million - $3.35 Million
29,279 Added 2.77%
1,086,131 $119 Million
Q3 2020

Nov 02, 2020

BUY
$91.64 - $111.29 $9.24 Million - $11.2 Million
100,783 Added 10.54%
1,056,852 $115 Million
Q2 2020

Aug 05, 2020

BUY
$76.57 - $98.0 $3.79 Million - $4.85 Million
49,443 Added 5.45%
956,069 $87.4 Million
Q1 2020

May 04, 2020

SELL
$62.82 - $91.86 $1.93 Million - $2.83 Million
-30,782 Reduced 3.28%
906,626 $71.5 Million
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $129,541 - $144,210
-1,650 Reduced 0.18%
937,408 $81.4 Million
Q3 2019

Nov 07, 2019

BUY
$81.84 - $88.74 $42.3 Million - $45.9 Million
516,850 Added 122.42%
939,058 $78.6 Million
Q2 2019

Jul 29, 2019

BUY
$72.88 - $85.0 $303,253 - $353,685
4,161 Added 1.0%
422,208 $35.5 Million
Q1 2019

Apr 25, 2019

BUY
$66.22 - $80.06 $2.7 Million - $3.26 Million
40,750 Added 10.8%
418,047 $33.4 Million
Q4 2018

Feb 11, 2019

BUY
$65.56 - $74.27 $909,054 - $1.03 Million
13,866 Added 3.82%
377,297 $27.3 Million
Q3 2018

Nov 05, 2018

BUY
$60.81 - $73.36 $12.7 Million - $15.3 Million
208,680 Added 134.85%
363,431 $26.7 Million
Q2 2018

Jul 31, 2018

BUY
$57.57 - $63.54 $105,928 - $116,913
1,840 Added 1.2%
154,751 $9.44 Million
Q1 2018

Apr 27, 2018

SELL
$56.27 - $63.62 $5.77 Million - $6.52 Million
-102,537 Reduced 40.14%
152,911 $9.16 Million
Q4 2017

Feb 05, 2018

SELL
$53.68 - $57.47 $9.3 Million - $9.96 Million
-173,284 Reduced 40.42%
255,448 $14.6 Million
Q3 2017

Nov 06, 2017

BUY
$48.06 - $53.64 $123,994 - $138,391
2,580 Added 0.61%
428,732 $22.9 Million
Q2 2017

Aug 09, 2017

BUY
N/A
426,152
426,152 $20.7 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.